non targeting scrambled control shrna vector sh scr (Addgene inc)
Addgene inc is a verified supplier 
96
Structured Review
Addgene inc
non targeting scrambled control shrna vector sh scr
Non Targeting Scrambled Control Shrna Vector Sh Scr, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1097 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+targeting+scrambled+control+shrna+vector+sh+scr/scramble+shRNA+(Plasmid+%231864)/pm36181640-55-1-10
Average 96 stars, based on 1097 article reviews
Non Targeting Scrambled Control Shrna Vector Sh Scr, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1097 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+targeting+scrambled+control+shrna+vector+sh+scr/scramble+shRNA+(Plasmid+%231864)/pm36181640-55-1-10
Average 96 stars, based on 1097 article reviews
non targeting scrambled control shrna vector sh scr - by Bioz Stars,
2026-11
96/100 stars
Images
Related Articles
Control:Article Title: Comparative oncology reveals DNMT3B as a molecular vulnerability in undifferentiated pleomorphic sarcoma. Article Snippet: Purpose Undifferentiated pleomorphic sarcoma (UPS), an aggressive subtype of soft-tissue sarcoma (STS), is exceedingly rare in humans and lacks effective, well-tolerated therapies.. In contrast, STS are relatively common in canine companion animals.. Thus, incorporation of veterinary patients into studies of UPS offers an exciting opportunity to develop novel therapeutic strategies for this rare human disease. shRNA:Article Title: Comparative oncology reveals DNMT3B as a molecular vulnerability in undifferentiated pleomorphic sarcoma. Article Snippet: Purpose Undifferentiated pleomorphic sarcoma (UPS), an aggressive subtype of soft-tissue sarcoma (STS), is exceedingly rare in humans and lacks effective, well-tolerated therapies.. In contrast, STS are relatively common in canine companion animals.. Thus, incorporation of veterinary patients into studies of UPS offers an exciting opportunity to develop novel therapeutic strategies for this rare human disease. |